Shougang Langze releases plan for listing on the main board of the Hong Kong Stock Exchange, with certification support, creating a leading advantage in the CCUS industry

Recently, Hong Kong Beijing Shougang Langze Technology Co., Ltd. officially announced that its global offering shares will be listed on the main board of the Hong Kong Stock Exchange Limited. This listing plan not only injects strong capital momentum into the company's technological innovation and capacity expansion, but also marks a new journey for this global enterprise in the field of carbon capture, utilization, and storage (CCUS).

Clear purpose of fundraising, focusing on core business development

Based on an offering price of HKD 16.69, the expected net proceeds from this sale are approximately HKD 284.4 million. The funds will be invested in multiple directions, including precise focus on the construction of production facilities, technological upgrades, and new product research and development. Approximately 37.9% will be used to support the construction and development of SAF production facilities in Baotou, Inner Mongolia over the next three years; About 21.2% will be used for the construction of Hebei Shoulang Phase II production facilities in the next two years; About 11.4% will be used for the research and development of strains, production equipment and processes, and intelligent production management systems in the next three years; About 14.1% is used for technological upgrades of four production facilities; About 5.3% will be used for new product development in the next three years; About 10.0% is used for general company purposes and working capital needs. This listing plan will help Shougang Langze further expand in the CCUS field and consolidate its industry-leading position.

Deeply cultivate the CCUS field and establish an advantageous position in the industry

As a pioneer in the CCUS industry, Shougang Langze has been dedicated to using synthetic biotechnology to capture carbon from industrial exhaust gas, convert it into low-carbon products such as bioethanol and microbial proteins, and provide comprehensive low-carbon solutions since its establishment in 2011. According to Frost&Sullivan data, the company is the first enterprise in the industry to commercialize synthetic biotechnology and produce low-carbon products on a large scale, with multiple breakthrough innovative achievements. The company has built the world's first industrial facility that uses carbon containing industrial exhaust gas from steel and ferroalloy plants to produce ethanol and microbial protein through biological fermentation technology, and has developed second-generation negative carbon technology using carbon dioxide, carbon monoxide, and hydrogen as raw materials.

The company has achieved remarkable results in the CCUS field, with multiple breakthrough innovative achievements, and has also obtained numerous international and domestic authoritative certifications, demonstrating its strength and position in the industry. The company has obtained certification from the International Roundtable on Sustainable Biomaterials (RSB) through advanced technology and high-quality products. Its biofuel related technologies and products have been included in the International Energy Agency's biofuel case study, which is a high recognition of the company's innovative achievements in the field of biofuels by the International Energy Agency; At the same time, the company has also obtained the International Sustainability and Carbon Certification (ISCC PLUS) and the International Aviation Carbon Offset and Reduction Program Certification (ISCC CORSIA). In China, the company has also achieved outstanding results, obtaining the first carbon label usage right certification in the domestic ethanol industry, obtaining low-carbon product supplier certification, and obtaining the first new feed raw material product certificate.